LWCFA
WST icon

Loring Wolcott & Coolidge Fiduciary Advisors’s West Pharmaceutical WST Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51K Hold
7
– – ﹤0.01% 555
2026
Q1 		$1.8K Buy
+7
New +$1.74K ﹤0.01% 551
2021
Q1 		– Sell
-11
Closed -$3K – 717
2020
Q4 		$3K Buy
+11
New +$3.09K ﹤0.01% 734

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's WST Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors held its West Pharmaceutical (WST) position steady in Q2 2026 at 7 shares worth $2.51K. The position accounts for ﹤0.01% of the portfolio, ranked #555.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in WST in Q4 2020 and has held it in 3 quarters since. The position peaked at $3K in Q4 2020. 569 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors held 7 shares of West Pharmaceutical worth $2.51K as of Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #555 holding.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in West Pharmaceutical in Q4 2020 and has held it in 3 quarters since.
  • Loring Wolcott & Coolidge Fiduciary Advisors's West Pharmaceutical position peaked at $3K in Q4 2020.
  • 569 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.